These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28970269)

  • 21. Inventory of antibiotic stewardship programs in general practice in France and abroad.
    Wang S; Pulcini C; Rabaud C; Boivin JM; Birgé J
    Med Mal Infect; 2015 Apr; 45(4):111-23. PubMed ID: 25747501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospects and challenges in anti-infective research and development: new drugs and approaches.
    Labischinski H; Ruebsamen-Waigmann H
    Curr Opin Pharmacol; 2008 Oct; 8(5):519-21. PubMed ID: 18848903
    [No Abstract]   [Full Text] [Related]  

  • 23. Infectious disorders. Introduction.
    Goldman RC
    Curr Drug Targets Infect Disord; 2001 May; 1(1):2p. PubMed ID: 12455228
    [No Abstract]   [Full Text] [Related]  

  • 24. 'Esprit de corps': Towards collaborative integration of pharmacists and nurses into antimicrobial stewardship programmes in South Africa.
    Schellack N; Pretorius R; Messina AP
    S Afr Med J; 2016 Sep; 106(10):973-974. PubMed ID: 27725011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Developments in Wound Management: intelligent biomaterials to novel antimicrobials. 24 September 2009, London, UK.
    Martin C
    IDrugs; 2009 Nov; 12(11):695-8. PubMed ID: 19844855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful concept: proteases as targets for anti-infectives. New targets in the treatment of infection].
    Schirmeister T; Welker A
    Pharm Unserer Zeit; 2009; 38(6):564-74; quiz 576-7. PubMed ID: 19862729
    [No Abstract]   [Full Text] [Related]  

  • 27. The place of quinolones in medicine today.
    Oh HM
    Singapore Med J; 1994 Dec; 35(6):562-4. PubMed ID: 7761876
    [No Abstract]   [Full Text] [Related]  

  • 28. Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda.
    Brett A; Bielicki J; Newland JG; Rodrigues F; Schaad UB; Sharland M
    Pediatr Infect Dis J; 2013 Dec; 32(12):e456-65. PubMed ID: 23958812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiothérapie du sujet âgé : On peut toujours mieux faire.
    Tolsma V; Gaillat J; Pagani L
    Can J Aging; 2016 Sep; 35(3):385-92. PubMed ID: 27291454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial use in nursing homes.
    Mylotte J
    J Am Geriatr Soc; 2009 May; 57(5):937-8. PubMed ID: 19470026
    [No Abstract]   [Full Text] [Related]  

  • 31. The tragedy of the commons in antimicrobial chemotherapy.
    Baquero F; Campos J
    Rev Esp Quimioter; 2003 Mar; 16(1):11-3. PubMed ID: 12750754
    [No Abstract]   [Full Text] [Related]  

  • 32. Jim O'Neill.
    Nat Rev Drug Discov; 2016 Jul; 15(8):526. PubMed ID: 27469228
    [No Abstract]   [Full Text] [Related]  

  • 33. The BfT-GermVet monitoring program--aims and basics.
    Schwarz S; Alesík E; Grobbel M; Lübke-Becker A; Wallmann J; Werckenthin C; Wieler LH
    Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):357-62. PubMed ID: 17939450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Surveillance Subgroup.
    Hayward AC; Goldsmith K; Johnson AM;
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i33-42. PubMed ID: 17656379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. United Nations meeting on antimicrobial resistance.
    Bull World Health Organ; 2016 Sep; 94(9):638-639. PubMed ID: 27708467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic properties of antibacterial agents and their clinical usage.
    Jacob L
    J Am Podiatr Med Assoc; 1985 Mar; 75(3):132-41. PubMed ID: 3981443
    [No Abstract]   [Full Text] [Related]  

  • 37. New strategies and tools to identify drug targets on infectious disorders.
    Garcia-Sanz JA
    Infect Disord Drug Targets; 2008 Dec; 8(4):206. PubMed ID: 19075795
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic considerations in the treatment of severe infections.
    Bellmann R
    Curr Clin Pharmacol; 2013 Feb; 8(1):3-4. PubMed ID: 23391252
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
    Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
    J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "infection equation".
    Ringoir S
    Infection; 1992; 20 Suppl 1():S75-7. PubMed ID: 1526685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.